Krystal Biotech, Inc.
NASDAQ:KRYS
182.74 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 70.284 | 45.25 | 42.143 | 8.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.542 | 0.583 | 1.027 | 0.217 | 0.173 | 0.127 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 7.995 | 2.419 | 4.378 | 0.223 | 1.2 | 1.1 | 1.089 | 0.975 | 0.976 | 1.015 | 0.784 | 0.783 | 0.665 | 0.536 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 62.289 | 42.831 | 37.765 | 8.333 | -1.2 | -1.1 | -1.089 | -0.975 | -0.976 | -1.015 | -0.784 | -0.783 | -0.665 | -0.536 | 0 | 0 | 0 | 0 | 0 | 0 | 0.542 | 0.583 | 1.027 | 0.217 | 0.173 | 0.127 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.886 | 0.947 | 0.896 | 0.974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 15.583 | 10.957 | 11.37 | 10.629 | 12.144 | 12.288 | 10.741 | 11.516 | 10.89 | 9.314 | 9.009 | 6.08 | 6.594 | 6.201 | 5.672 | 5.1 | 3.639 | 3.525 | 4.349 | 3.885 | 4.216 | 3.167 | 2.802 | 1.914 | 1.525 | 1.52 | 1.088 | 1.355 | 0.446 | 0.319 | 0.402 | 0.241 |
| General & Administrative Expenses
| 0 | 0 | 73.636 | 23.697 | 25.904 | 24.035 | 24.03 | 19.935 | 17.863 | 15.908 | 12.867 | 9.572 | 9.799 | 8.152 | 4.748 | 4.58 | 3.315 | 2.421 | 1.805 | 1.457 | 1.674 | 1.527 | 1.417 | 1.058 | 0.924 | 0.757 | 0.41 | 0.738 | 0.269 | 0.146 | 0.218 | 0.081 |
| Selling & Marketing Expenses
| 0 | 0 | -50.379 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 25.64 | 26.058 | 23.257 | 23.697 | 25.904 | 24.035 | 24.03 | 19.935 | 17.863 | 15.908 | 12.867 | 9.572 | 9.799 | 8.152 | 4.748 | 4.58 | 3.315 | 2.421 | 1.805 | 1.457 | 1.674 | 1.527 | 1.417 | 1.058 | 0.924 | 0.757 | 0.41 | 0.738 | 0.269 | 0.146 | 0.218 | 0.081 |
| Other Expenses
| 18.509 | 14.919 | 2.871 | 0.223 | 0 | 12.5 | 25 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 41.223 | 37.015 | 34.627 | 34.549 | 38.048 | 36.323 | 34.771 | 31.451 | 28.753 | 25.222 | 21.876 | 15.652 | 16.393 | 14.353 | 10.42 | 9.68 | 6.954 | 5.946 | 6.154 | 5.342 | 5.89 | 4.694 | 4.219 | 2.972 | 2.449 | 2.277 | 1.498 | 2.093 | 0.715 | 0.465 | 0.62 | 0.322 |
| Operating Income
| 21.066 | -6.684 | 3.138 | -25.993 | -38.048 | -48.823 | -34.771 | -31.451 | -28.753 | -50.222 | -21.876 | -15.652 | -16.393 | -14.353 | -10.42 | -9.68 | -6.954 | -5.946 | -6.154 | -5.342 | -5.89 | -4.694 | -4.219 | -2.972 | -2.449 | -2.277 | -1.498 | -2.093 | -0.715 | -0.465 | -0.62 | -0.322 |
| Operating Income Ratio
| 0.3 | -0.148 | 0.074 | -3.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.867 | -8.051 | -4.108 | -13.696 | -14.156 | -17.929 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -5.021 | -12.5 | 7.519 | 106.74 | 4.838 | 3.526 | 2.719 | 1.601 | 0.645 | 0.257 | 0.071 | 0.063 | 0.03 | -1.459 | 0.037 | 0.07 | 0.121 | 0.605 | 0.797 | 1.07 | 0.542 | 0.583 | 0.511 | 0.217 | 0.173 | 0.127 | 0.105 | -3.18 | -0.044 | -0.029 | -0.007 | 0 |
| Income Before Tax
| 16.045 | 0.932 | 10.657 | 80.747 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 | -49.965 | -21.806 | -15.589 | -16.363 | -15.812 | -10.383 | -9.61 | -6.833 | -5.341 | -5.357 | -4.272 | -5.348 | -4.111 | -3.708 | -2.755 | -2.276 | -2.15 | -1.393 | -5.273 | -0.759 | -0.494 | -0.627 | -0.322 |
| Income Before Tax Ratio
| 0.228 | 0.021 | 0.253 | 9.437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.867 | -7.051 | -3.611 | -12.696 | -13.156 | -16.929 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.477 | 4.884 | 1.965 | -0.826 | 0.996 | 25.65 | 2.503 | 2.49 | 0.645 | 25.257 | 0.071 | 0.063 | 0.031 | 0.033 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 15.568 | 0.932 | 8.692 | 80.747 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 | -49.965 | -21.806 | -15.589 | -16.363 | -15.812 | -10.383 | -9.61 | -6.833 | -5.341 | -5.357 | -4.272 | -5.348 | -4.111 | -3.708 | -2.755 | -2.276 | -2.15 | -1.393 | -5.273 | -0.759 | -0.494 | -0.627 | -0.322 |
| Net Income Ratio
| 0.222 | 0.021 | 0.206 | 9.437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.867 | -7.051 | -3.611 | -12.696 | -13.156 | -16.929 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.54 | 0.03 | 0.31 | 2.88 | -1.25 | -1.76 | -1.25 | -1.17 | -1.1 | -1.99 | -0.95 | -0.7 | -0.74 | -0.74 | -0.53 | -0.49 | -0.37 | -0.31 | -0.31 | -0.25 | -0.37 | -0.29 | -0.27 | -0.26 | -0.22 | -0.21 | -0.14 | -1.26 | -0.087 | -0.12 | -0.15 | -0.075 |
| EPS Diluted
| 0.53 | 0.03 | 0.3 | 2.79 | -1.25 | -1.76 | -1.25 | -1.17 | -1.1 | -1.99 | -0.94 | -0.7 | -0.74 | -0.74 | -0.53 | -0.49 | -0.37 | -0.31 | -0.31 | -0.25 | -0.37 | -0.29 | -0.27 | -0.26 | -0.22 | -0.21 | -0.14 | -1.26 | -0.087 | -0.12 | -0.15 | -0.075 |
| EBITDA
| 23.052 | 19.925 | 4.645 | -25.993 | -37.01 | -23.118 | -30.963 | -28.875 | -27.132 | -23.95 | -21.022 | -14.806 | -15.697 | -13.784 | -9.93 | -9.203 | -6.405 | -5.611 | -5.904 | -5.151 | -5.715 | -4.562 | -4.158 | -2.934 | -2.425 | -2.259 | -1.484 | -2.088 | -0.712 | -0.464 | -0.619 | -0.322 |
| EBITDA Ratio
| 0.328 | 0.44 | 0.11 | -3.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.544 | -7.825 | -4.049 | -13.521 | -14.017 | -17.787 | 0 | 0 | 0 | 0 | 0 | 0 |